Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jeffrey R Olsen

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Radiation Oncology
Phone719/365-5739

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hallemeier CL, Olsen JR, Murphy JD, Tait D, Apisarnthanarax S, Huguet F, Jabbour SK. Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers. Int J Radiat Oncol Biol Phys. 2019 May 01; 104(1):1-9. PMID: 30967220.
      View in: PubMed
    2. Ladbury C, A Goodman K, Schefter TE, Olsen JR. Anal Cancer in the Era of Dose Painted Intensity Modulated Radiation Therapy: Implications for Regional Nodal Therapy. Semin Radiat Oncol. 2019 04; 29(2):137-143. PMID: 30827451.
      View in: PubMed
    3. Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, Bassetti MF, Parikh PJ, Lee PP. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019 Apr 01. PMID: 30932367.
      View in: PubMed
    4. Olsen JR, Schefter TE. SBRT as a Favored Ablative Therapy for Stage I HCC. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1406. PMID: 31014784.
      View in: PubMed
    5. Henke LE, Olsen JR, Contreras JA, Curcuru A, DeWees TA, Green OL, Michalski J, Mutic S, Roach MC, Bradley JD, Parikh PJ, Kashani R, Robinson CG. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):201-209. PMID: 30706029.
      View in: PubMed
    6. Olsen JR, Murphy JD, Huguet F, Hallemeier CL, Apisarnthanarax S, Jabbour SK. Gastrointestinal Cancers-Carving Out the Optimal Local Therapies in the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):233-242. PMID: 30191854.
      View in: PubMed
    7. Gui B, Weiner AA, Nosher J, Lu SE, Foltz GM, Hasan O, Kim SK, Gendel V, Mani NB, Carpizo DR, Saad NE, Kennedy TJ, Zuckerman DA, Olsen JR, Parikh PJ, Jabbour SK. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Am J Clin Oncol. 2018 Sep; 41(9):861-866. PMID: 28418940.
      View in: PubMed
    8. Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):142-149. PMID: 30706022.
      View in: PubMed
    9. Olsen JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, Huguet F, Jabbour SK. Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database. J Clin Oncol. 2018 Aug 20; 36(24):2564-2565. PMID: 29945521.
      View in: PubMed
    10. Jabbour SK, Apisarnthanarax S, Hallemeier CL, Huguet F, Murphy JD, Olsen JR. GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):749-758. PMID: 29976479.
      View in: PubMed
    11. Kashani R, Olsen JR. Magnetic Resonance Imaging for Target Delineation and Daily Treatment Modification. Semin Radiat Oncol. 2018 06; 28(3):178-184. PMID: 29933877.
      View in: PubMed
    12. Green OL, Rankine LJ, Cai B, Curcuru A, Kashani R, Rodriguez V, Li HH, Parikh PJ, Robinson CG, Olsen JR, Mutic S, Goddu SM, Santanam L. First clinical implementation of real-time, real anatomy tracking and radiation beam control. Med Phys. 2018 May 28. PMID: 29807390.
      View in: PubMed
    13. Weiner AA, Gui B, Newman NB, Nosher JL, Yousseff F, Lu SE, Foltz GM, Carpizo D, Lowenthal J, Zuckerman DA, Benson B, Olsen JR, Jabbour SK, Parikh PJ. Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases. J Vasc Interv Radiol. 2018 08; 29(8):1094-1100. PMID: 29754852.
      View in: PubMed
    14. Apisarnthanarax S, Jabbour SK, Liauw SL, Murphy JD, Olsen JR, Chang DT. Gastrointestinal Cancers: Timing Is Everything. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1051-1058. PMID: 29165271.
      View in: PubMed
    15. Markovina S, Youssef F, Roy A, Aggarwal S, Khwaja S, DeWees T, Tan B, Hunt S, Myerson RJ, Chang DT, Parikh PJ, Olsen JR. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):417-426. PMID: 28871992.
      View in: PubMed
    16. Fischer-Valuck BW, Henke L, Green O, Kashani R, Acharya S, Bradley JD, Robinson CG, Thomas M, Zoberi I, Thorstad W, Gay H, Huang J, Roach M, Rodriguez V, Santanam L, Li H, Li H, Contreras J, Mazur T, Hallahan D, Olsen JR, Parikh P, Mutic S, Michalski J. Two-and-a-half-year clinical experience with the world's first magnetic resonance image guided radiation therapy system. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):485-493. PMID: 29114617.
      View in: PubMed
    17. Cardenas ML, Spencer CR, Markovina S, DeWees TA, Mazur TR, Weiner AA, Parikh PJ, Olsen JR. Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):281-287. PMID: 29114593.
      View in: PubMed
    18. Olsen JR, Moughan J, Myerson R, Abitbol A, Doncals DE, Johnson D, Schefter TE, Chen Y, Fisher B, Michalski J, Narayan S, Chang A, Crane CH, Kachnic L. Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):400-408. PMID: 28463160.
      View in: PubMed
    19. Cai B, Altman MB, Garcia-Ramirez J, LaBrash J, Goddu SM, Mutic S, Parikh PJ, Olsen JR, Saad N, Zoberi JE. Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy. Brachytherapy. 2017 Jan - Feb; 16(1):236-244. PMID: 27618420.
      View in: PubMed
    20. Roy A, Mahasittiwat P, Weiner AA, Hunt SR, Mutch MG, Birnbaum EH, Kodner IJ, Read TE, Fleshman JW, Olsen JR, Myerson RJ, Parikh PJ. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e51-e58. PMID: 27720702.
      View in: PubMed
    21. Henke L, Kashani R, Yang D, Zhao T, Green O, Olsen L, Rodriguez V, Wooten HO, Li HH, Hu Y, Bradley J, Robinson C, Parikh P, Michalski J, Mutic S, Olsen JR. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1078-1086. PMID: 27742541.
      View in: PubMed
    22. Khwaja SS, Roy A, Markovina S, Dewees TA, Hunt S, Tan B, Myerson RJ, Olsen JR, Parikh PJ. Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1429-1438. PMID: 27209506.
      View in: PubMed
    23. Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan BR, Grigsby PW, Myerson RJ, Olsen JR. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Adv Radiat Oncol. 2016 Apr-Jun; 1(2):94-100. PMID: 28740875.
      View in: PubMed
    24. Badiyan SN, Olsen JR, Lee AY, Yano M, Menias CO, Khwaja S, Wang-Gillam A, Strasberg SM, Hawkins WG, Linehan DC, Myerson RJ, Parikh PJ. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Am J Clin Oncol. 2016 Feb; 39(1):1-7. PMID: 26132367.
      View in: PubMed
    25. Elhammali A, Patel M, Weinberg B, Verma V, Liu J, Olsen JR, Gay HA. Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas. Radiat Oncol. 2015 Sep 04; 10:186. PMID: 26337917.
      View in: PubMed
    26. Noel CE, Parikh PJ, Spencer CR, Green OL, Hu Y, Mutic S, Olsen JR. Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy. Acta Oncol. 2015; 54(9):1474-82. PMID: 26206517.
      View in: PubMed
    27. Du L, DeFoe M, Ruzinova MB, Olsen JR, Wang-Gillam A. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am. 2015 Aug; 29(4):717-26. PMID: 26226906.
      View in: PubMed
    28. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RLM, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059. PMID: 26194680.
      View in: PubMed
    29. Hu Y, Zhao W, Du D, Wooten HO, Olsen JR, Gay HA, Michalski JM, Mutic S. Magnetic resonance imaging-based treatment planning for prostate cancer: Use of population average tissue densities within the irradiated volume to improve plan accuracy. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):248-56. PMID: 25649539.
      View in: PubMed
    30. Olsen JR, Michalski JM. PSA screening for colorectal cancer patients: proceeding with caution. Oncology (Williston Park). 2013 Oct; 27(10):1041-2. PMID: 24367866.
      View in: PubMed
    31. Robinson CG, DeWees TA, El Naqa IM, Creach KM, Olsen JR, Crabtree TD, Meyers BF, Puri V, Bell JM, Parikh PJ, Bradley JD. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol. 2013 Feb; 8(2):192-201. PMID: 23287852.
      View in: PubMed
    32. Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa AA, Dewees T, Bradley JD, Robinson CG. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat Oncol. 2013 Jan 03; 8:4. PMID: 23286648.
      View in: PubMed
    33. Olsen JR, Esthappan J, DeWees T, Narra VR, Dehdashti F, Siegel BA, Schwarz JK, Grigsby PW. Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix. J Magn Reson Imaging. 2013 Feb; 37(2):431-4. PMID: 23023940.
      View in: PubMed
    34. Olsen JR, Parikh PJ, Watts M, Noel CE, Baker KW, Santanam L, Michalski JM. Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy. Radiother Oncol. 2012 Aug; 104(2):199-204. PMID: 22809590.
      View in: PubMed
    35. Creach KM, El Naqa I, Bradley JD, Olsen JR, Parikh PJ, Drzymala RE, Bloch C, Robinson CG. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. Radiother Oncol. 2012 Jul; 104(1):23-7. PMID: 22385795.
      View in: PubMed
    36. Olsen JR, Robinson CG, El Naqa I, Creach KM, Drzymala RE, Bloch C, Parikh PJ, Bradley JD. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e299-303. PMID: 21477948.
      View in: PubMed
    37. Olsen JR, Noel CE, Baker K, Santanam L, Michalski JM, Parikh PJ. Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1903-11. PMID: 21470786.
      View in: PubMed
    38. Olsen JR, Dehdashti F, Siegel BA, Zighelboim I, Grigsby PW, Schwarz JK. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):772-7. PMID: 20888130.
      View in: PubMed
    39. Olsen JR, Lu W, Hubenschmidt JP, Nystrom MM, Klahr P, Bradley JD, Low DA, Parikh PJ. Effect of novel amplitude/phase binning algorithm on commercial four-dimensional computed tomography quality. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):243-52. PMID: 18037590.
      View in: PubMed
    40. Martin MB, Sanders JM, Kendrick H, de Luca-Fradley K, Lewis JC, Grimley JS, Van Brussel EM, Olsen JR, Meints GA, Burzynska A, Kafarski P, Croft SL, Oldfield E. Activity of bisphosphonates against Trypanosoma brucei rhodesiense. J Med Chem. 2002 Jul 04; 45(14):2904-14. PMID: 12086478.
      View in: PubMed
    Olsen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (180) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)